Reefrad,
Linda said that they would continue to prepare for commercialization and that there might be some obstacles along the way. Rkmatters has very kindly taken the necessary time to show us what Linda Powers was hinting at when mentioning manufacturing issues being a major reason for partial or full clinical holds. As you have noted, NWBO's current situation, and clues given about it, pretty much is the foot that fits the shoe of Rkmatters' perspective. How long will the translations take for the finalized patent approval submission or might they already be done? Remember, one of the best friends of big business and worst enemies of cancer patients, small business and small investors is bureaucracy. Still, May is installation month. Tic Toc. Best wishes.
News 
Market Data 
Discover 
